Folding and function in α/β-peptides: Targets and therapeutic applications

Current Opinion in Chemical Biology

Volumn 28, Issue , 2015, Pages 75-82

  Werner, Halina M ^a   Horne, W Seth ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO ACID; BETA AMINO ACID; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLYCOPROTEIN GP 41; NEUROPEPTIDE Y; OLIGOMER; PARATHYROID HORMONE; PROTEIN BCL 2; VIRUS PROTEIN; ANGIOGENIC FACTOR; ANTIVIRUS AGENT; PEPTIDE;

AMINO ACID SEQUENCE; ANGIOGENESIS; APOPTOSIS; BINDING AFFINITY; BIOLOGICAL FUNCTIONS; CELL FUSION; ENZYMATIC DEGRADATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; IN VIVO STUDY; PHAGE DISPLAY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; HIV INFECTIONS; METABOLISM; MOLECULAR GENETICS; MOLECULAR MODEL; PROCEDURES; PROTEIN SECONDARY STRUCTURE;

AMINO ACID SEQUENCE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; DRUG DISCOVERY; HIV; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84933044552     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2015.06.013     Document Type: Review

References (50)

1. Arkin M.R., Tang Y., Wells J.A. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Chem Biol 2014, 21:1102-1114.
2. Fosgerau K., Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today 2015, 20:122-128.
3. Bautista A.D., Craig C.J., Harker E.A., Schepartz A. Sophistication of foldamer form and function in vitro and in vivo. Curr Opin Chem Biol 2007, 11:685-692.
4. Goodman C.M., Choi S., Shandler S., DeGrado W.F. Foldamers as versatile frameworks for the design and evolution of function. Nat Chem Biol 2007, 3:252-262.
5. Guichard G., Huc I. Synthetic foldamers. Chem Commun 2011, 47:5933-5941.
6. Horne W.S. Peptide and peptoid foldamers in medicinal chemistry. Expert Opin Drug Discov 2011, 6:1247-1262.
7. Horne W.S., Gellman S.H. Foldamers with heterogeneous backbones. Acc Chem Res 2008, 41:1399-1408.
8. Pilsl L.K.A., Reiser O. α/β-Peptide foldamers: state of the art. Amino Acids 2011, 41:709-718.
9. Johnson L.M., Gellman S.H. α-Helix mimicry with α/β-peptides. Methods Enzymol 2013, 523:407-429.
10. Cabrele C., Martinek T.A., Reiser O., Berlicki Ł. Peptides containing β-amino acid patterns: challenges and successes in medicinal chemistry. J Med Chem 2014, 57:9718-9739.
11. Chipuk J.E., Moldoveanu T., Llambi F., Parsons M.J., Green D.R. The Bcl-2 family reunion. Molecular Cell 2010, 37:299-310.
12. Czabotar P.E., Lessene G., Strasser A., Adams J.M. Control of apoptosis by the Bcl-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014, 15:49-63.
13. Hayen A., Schmitt M.A., Ngassa F.N., Thomasson K.A., Gellman S.H. Two helical conformations from a single foldamer backbone: "split personality" in short α/β-peptides. Angew Chem Int Ed 2004, 43:505-510.
14. De Pol S., Zorn C., Klein C.D., Zerbe O., Reiser O. Surprisingly stable helical conformations in α/β-peptides by incorporation of cis-β-aminocyclopropane carboxylic acids. Angew Chem Int Ed 2004, 43:511-514.
15. L recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions. J Am Chem Soc 2007, 129:139-154.
16. Horne W.S., Boersma M.D., Windsor M.A., Gellman S.H. Sequence-based design of α/β-peptide foldamers that mimic BH3 domains. Angew Chem Int Ed 2008, 47:2853-2856.
17. Horne W.S., Price J.L., Keck J.L., Gellman S.H. Helix bundle quaternary structure from α/β-peptide foldamers. J Am Chem Soc 2007, 129:4178-4180.
18. L recognition by a BH3-mimetic α/β-peptide generated by sequence-based design. ChemBioChem 2011, 12:2025-2032.
19. Smith B.J., Lee E.F., Checco J.W., Evangelista M., Gellman S.H., Fairlie W.D. Structure-guided rational design of α/β-peptide foldamers with high affinity for Bcl-2 family prosurvival proteins. ChemBioChem 2013, 14:1564-1572.
20. Boersma M.D., Haase H.S., Peterson-Kaufman K.J., Lee E.F., Clarke O.B., Colman P.M., Smith B.J., Horne W.S., Fairlie W.D., Gellman S.H. Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain. J Am Chem Soc 2012, 134:315-323.
21. Gallo S.A., Finnegan C.M., Viard M., Raviv Y., Dimitrov A., Rawat S.S., Puri A., Durell S., Blumenthal R. The HIV Env-mediated fusion reaction. BBA-Biomembranes 2003, 1614:36-50.
22. Matthews T., Salgo M., Greenberg M., Chung J., DeMasi R., Bolognesi D. Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes. Nat Rev Drug Discov 2004, 3:215-225.
23. Horne W.S., Johnson L.M., Ketas T.J., Klasse P.J., Lu M., Moore J.P., Gellman S.H. Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers. Proc Natl Acad Sci U S A 2009, 106:14751-14756.
24. Horne W.S., Price J.L., Gellman S.H. Interplay among side chain sequence, backbone composition, and residue rigidification in polypeptide folding and assembly. Proc Natl Acad Sci U S A 2008, 105:9151-9156.
25. Johnson L.M., Mortenson D.E., Yun H.G., Horne W.S., Ketas T.J., Lu M., Moore J.P., Gellman S.H. Enhancement of α-helix mimicry by an α/β-peptide foldamer via incorporation of a dense ionic side-chain array. J Am Chem Soc 2012, 134:7317-7320.
26. Reinert Z.E., Horne W.S. Folding thermodynamics of protein-like oligomers with heterogeneous backbones. Chem Sci 2014, 5:3325-3330.
27. Lagerstrom M.C., Schioth H.B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008, 7:339-357.
28. Overington J.P., Al-Lazikani B., Hopkins A.L. How many drug targets are there?. Nat Rev Drug Discov 2006, 5:993-996.
29. Bellmann-Sickert K., Beck-Sickinger A.G. Peptide drugs to target G protein-coupled receptors. Trends Pharmacol Sci 2010, 31:434-441.
30. Cabrele C., Beck-Sickinger A.G. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci 2000, 6:97-122.
31. 4 receptor. J Med Chem 2013, 56:8422-8431.
32. 1 receptor. Angew Chem Int Ed 2003, 42:202-205.
33. Gensure R.C., Gardella T.J., Jüppner H. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 2005, 328:666-678.
34. Vilardaga J.-P., Romero G., Friedman P., Gardella T. Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm. Cell Mol Life Sci 2011, 68:1-13.
35. Cheloha R.W., Maeda A., Dean T., Gardella T.J., Gellman S.H. Backbone modification of a polypeptide drug alters duration of action in vivo. Nat Biotechnol 2014, 32:653-655.
36. Lovshin J.A., Drucker D.J. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009, 5:262-269.
37. Johnson L.M., Barrick S., Hager M.V., McFedries A., Homan E.A., Rabaglia M.E., Keller M.P., Attie A.D., Saghatelian A., Bisello A., et al. A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo. J Am Chem Soc 2014, 136:12848-12851.
38. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
39. Fairbrother W.J., Christinger H.W., Cochran A.G., Fuh G., Keenan C.J., Quan C., Shriver S.K., Tom J.Y.K., Wells J.A., Cunningham B.C. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site. Biochemistry 1998, 37:17754-17764.
40. Haase H.S., Peterson-Kaufman K.J., Lan Levengood S.K., Checco J.W., Murphy W.L., Gellman S.H. Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling. J Am Chem Soc 2012, 134:7652-7655.
41. Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 2012, 320:130-137.
42. Croci D.O., Cerliani J.P., Dalotto-Moreno T., Mendez-Huergo S.P., Mascanfroni I.D., Dergan-Dylon S., Toscano M.A., Caramelo J.J., Garcia-Vallejo J.J., Ouyang J., et al. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 2014, 156:744-758.
43. van der Schaft D.W.J., Dings R.P.M., de Lussanet Q.G., van Eijk L.I., Nap A.W., Beets-Tan R.G.H., Bouma-Ter Steege J.C.A., Wagstaff J., Mayo K.H., Griffioen A.W. The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models. FASEB J 2002.
44. Thijssen V.L.J.L., Postel R., Brandwijk RJMGE, Dings R.P.M., Nesmelova I., Satijn S., Verhofstad N., Nakabeppu Y., Baum L.G., Bakkers J., et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 2006, 103:15975-15980.
45. Lengyel G.A., Horne W.S. Design strategies for the sequence-based mimicry of side-chain display in protein β-sheets by α/β-peptides. J Am Chem Soc 2012, 134:15906-15913.
46. Hegedüs Z., Wéber E., Kriston-Pál É., Makra I., Czibula Á., Monostori É., Martinek T.A. Foldameric α/β-peptide analogs of the β-sheet-forming antiangiogenic anginex: structure and bioactivity. J Am Chem Soc 2013, 135:16578-16584.
47. Löfblom J., Feldwisch J., Tolmachev V., Carlsson J., Ståhl S., Frejd F.Y. Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett 2010, 584:2670-2680.
48. Starovasnik M.A., Braisted A.C., Wells J.A. Structural mimicry of a native protein by a minimized binding domain. Proc Natl Acad Sci U S A 1997, 94:10080-10085.
49. Fedorova A., Zobel K., Gill H.S., Ogasawara A., Flores J.E., Tinianow J.N., Vanderbilt A.N., Wu P., Meng Y.G., Williams S.-P., et al. The development of peptide-based tools for the analysis of angiogenesis. Chem Biol 2011, 18:839-845.
50. Checco J.W., Kreitler D.F., Thomas N.C., Belair D.G., Rettko N.J., Murphy W.L., Forest K.T., Gellman S.H. Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold. Proc Natl Acad Sci U S A 2015, 112:4552-4557.